Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2013 by McGill University
Sponsor:
Collaborators:
St. Michael's Hospital, Toronto
Sunnybrook Health Sciences Centre
Queen Elizabeth II Health Sciences Centre
Information provided by (Responsible Party):
Mark Eisenberg, McGill University
ClinicalTrials.gov Identifier:
NCT00794573
First received: November 19, 2008
Last updated: December 10, 2013
Last verified: December 2013